U.S. Markets closed

Global Cholesterol Testing - Clinical Diagnostics

LONDON, April 6, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Thousands of Cholesterol Tests by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Download the full report: https://www.reportbuyer.com/product/4484194/

The report profiles 29 companies including many key and niche players such as -

Abbott Diagnostics, Inc.
AccuTech, LLC
Alere Inc.
Beckman Coulter, Inc.
Home Access Health Corporation


Download the full report: https://www.reportbuyer.com/product/4484194/



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Lipid Panel Test/Complete Lipid Profile
Total Cholesterol Test
HDL Cholesterol Test
LDL Cholesterol Testing
Triglycerides/VLDL Cholesterol Testing
B. Apolipoprotein B
C. Other Apolipoprotein Tests


II. EXECUTIVE SUMMARY


1. INDUSTRY OVERVIEW
Cholesterol Testing - An Overview
Current & Future Analysis
Increasing Healthcare Expenditure to Promote Testing Market
Table 1: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart)
Cholesterol Testing: Evolution from Invasive to Non-Invasive
Developing Economies Offer Significant Potential
Table 2: Healthcare Spending as Percentage of GDP in Select Developing Countries/Region (2014) (includes corresponding Graph/Chart)
Table 3: Healthcare Spending as Percentage of GDP in Select Developed Countries for 2010, 2012 & 2014 (includes corresponding Graph/Chart)


2. TRENDS, DRIVERS & CHALLENGES
Global Menace of Cardiovascular Disease - Major Growth Factor
Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
Lipid Panel Test - An Overview
Preventive Healthcare Trend to Expand Growth
Technological Advances to Improve Cholesterol Testing
Cholesterol Testing With Smartphone
Growing Smartphone Sales - A Business Case
Table 9: Top Ten Countries by Mobile Phone Subscriptions in Millions and Penetration Rate (2015) (includes corresponding Graph/Chart)
Table 10: Global Market for Smartphones: Volume Sales in Million Units for 2016, 2018 & 2020 (includes corresponding Graph/Chart)
Non-Invasive Cholesterol Tests to Drive Demand
Digital Photographs to Screen Cholesterol?
Miniature Sensors - The Future of Cholesterol Testing
Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers
The Rise of C-reactive Protein Tests
Global In-Vitro Diagnostics Market Signals Prospects
Table 11: Global In-Vitro Diagnostics Market by Test Category (2017): Percentage Breakdown of Value Sales for Anatomic Pathology, Blood Screen Immunoassay, Coagulation, Hematology, Immunoassay, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, and Others (includes corresponding Graph/Chart)
Table 12: Global In-Vitro Diagnostics Market by Sector (2017): Percentage Breakdown of Revenues for Decentralized & Patient Self-Testing, and Hospital & Commercial Laboratories (includes corresponding Graph/Chart)
Table 13: Global In-Vitro Diagnostics Market by Geographic Region (2015): Percentage Breakdown of Value Sales for the United States, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
Opportunities and Challenges in Self-Testing Industry
An Evolving Market Enabled by Technology
Cardiac IVD Market Offers Potential
Point of Care Testing: Potential Opportunities Ahead
Point of Care Diagnostics - An Overview
Complexities in the POC Diagnostics Market
POC Cholesterol Testing
Aging Population - A Vital Demography for Cholesterol Testing
Table 14: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (mid-2016) (includes corresponding Graph/Chart)
Table 15: Global Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Risk of CVD in Obesity Offers Prospects for Cholesterol Testing
Table 16: Global Obese Population in Millions by Region/ Country (2413) (includes corresponding Graph/Chart)
Table 17: Global Obesity Levels (2013): Percentage Share Breakdown of Total Obese Population by Leading Countries (includes corresponding Graph/Chart)
Diabetics at Higher Risk of Heart Diseases
Table 18: Worldwide Prevalence of Diabetes Mellitus by Geographic Region (2013 & 2035P) (includes corresponding Graph/Chart)
The Hypertension-Cholesterol Link to Drive Demand
Table 19: Death Rates Due to Hypertension in Select Countries
Table 20: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 & 2010) (includes corresponding Graph/Chart)
E-Retailing Drives Demand for Home Test Kits
Table 21: Factors Influencing Online Purchase Decision - Percentage Share Breakdown of Consumer Preferences by Criteria (includes corresponding Graph/Chart)


3. AN INSIGHT INTO CARDIOVASCULAR DISEASES
The Heart of Heart Problems
Types of Cardiovascular Diseases/Disorders
Coronary Artery Disease
Hyperlipidemia - An Important Risk Factor of Heart Disease
Hypertension - The Silent Killer
Two-Pronged Approach to Counter CVD
Cardiovascular Risk Assessment
Reality Check


4. GOOD & BAD OF CHOLESTEROL
Blood Cholesterol - The Principal Cardiac Risk Marker
Types of Cholesterol
Total Cholesterol (TC)
High Density Lipoprotein (HDL)
Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL)
Triglycerides (TRG)
Glucose (GLU)
Alanine Aminotransferase (ALT)
Outcomes of High Blood Cholesterol
Atherosclerosis
Coronary Heart Disease (CHD)
Risk Factors and Risk Levels
Risk Factors
Risk Levels
Risk Level Based on Total Cholesterol Concentration
LDL-Cholesterol Risk Levels
HDL-Cholesterol Risk Levels
Triglyceride Risk Levels


5. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES
Cholesterol Testing
Need for Cholesterol Testing
Candidates for Cholesterol Testing
Test Procedure
Time of Testing - Crucial for Heart Disease Patients
Types of Cholesterol Testing
Lipid Panel Test/Lipid Profile
Total Cholesterol Test
HDL Cholesterol Test
LDL Cholesterol Testing
LDL Cholesterol Test - The First Cholesterol Testing Method
Triglycerides/VLDL Cholesterol Testing
Apolipoprotein B Test
Other Cholesterol Tests
Apolipoprotein A-1 Test
ApoE Genotyping Test
Apolipoprotein CII
Other Key Markers for Cholesterol Testing
RLP Cholesterol
Non Instrumented Technologies
Heart Disease Diagnosis Tests
Non-Invasive Tests
Invasive Tests
Other CVD Markers
Creatine Kinase MB
Troponin T and Troponin I
Myoglobin
P-selectin Profile
C-reactive Protein
Endothelial Dysfunction
Homocysteine
Plasminogen Activator Inhibitor-1
s-100 Protein
Thrombus Precursor Protein
Other Cardiac Markers


6. POINT OF CARE & HOME CHOLESTEROL TESTING
Point of Care (POC) Medical Diagnostics
Table 22: Global Point of Care Diagnostics Market by Segment (2013): Percentage Breakdown of Revenues for Commercial Labs, Hospital Labs, Point of Care and Self Testing (includes corresponding Graph/Chart)
POC Testing Market
Table 23: Global Point-of-Care Diagnostics Market by POC Tests (2015): Percentage Share Breakdown of Revenues for Blood Chemistry, Cardiac Markers, Cholesterol, Drug & Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, and Others (includes corresponding Graph/Chart)
Development of Home Cholesterol Testing Kits
Cholesterol and Other Cardiovascular Test Kits Offered by Select Companies
Select Cholesterol Test Kits
CardioChek Analyzer Starter Kit from PTS Panels
EasyLife Cholesterol Test Strips
CholesTrak Home Test Kit 2 ea
Easylife Glucose, Uric Acid, Cholesterol Test Kit
Accurate Home Test Kit
Best Home Complete HDL, Lipid Panel LDL, and Triglycerides Test Kit
PRIMA 2-in-1 Home Test/Meter for Cholesterol and Triglycerides
Cardio Chek Deluxe
Cholestrak Home Testing Kit for Total Cholesterol
Cardio Chek Starter from PTS Panels
LifeSign DietMate
EasyLife Test Meter Kit for Cholesterol, Hemoglobin, and Glucose
Cardiocheck Blood Testing Kit
Best Home Complete Cholesterol Test
Prima 3-in-1 Home Test
Best Home Testing Kit for Cholesterol, Tot, HDL, LDL, and Triglycerides
Portable CardioCheck Blood Test System 1 ea
Cardio Check Refil Kits
Roche Diagnostics' Accurate Plus System
LifeDesign DietMate—a Handheld Computer for Cholesterol, Hypertension, and Weight Control


7. CHOLESTEROL CONTROL & TREATMENT MODALITIES
Prevention is better than Cure
Dietary Therapy
Healthy Diet
Exercises
Drug Therapy
Classification of Cholesterol Lowering Drugs
Bile Acid Sequestrants
Nicotinic Acid
HMG CoA Reductase Inhibitors (Statins)
Other Drugs (Fibric Acids and Probucol)
Testing After Commencing Drug Therapy


8. PRODUCT INTRODUCTIONS
Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma Ceramides
CODIX Introduces SelexOn™
9. RECENT INDUSTRY ACTIVITY
Sinocare Acquires PTS Diagnostics
LabCorp Acquires LipoScience
PTS Switches Name to Chek Diagnostics
LipoScience Parts Ways with Health Diagnostics
Miraculins and Citizen Doctor Sign Distribution Deal
Akers Biosciences Signs Distribution Deal for Rapid Tests in Australia, Singapore & Middle East
10. FOCUS ON SELECT PLAYERS
Abbott Diagnostics, Inc. (US)
AccuTech, LLC (US)
Alere Inc. (US)
Beckman Coulter, Inc. (US)
Home Access Health Corporation (US)
PTS Diagnostics (US)
Roche Diagnostics (US)
Siemens Healthineers (Germany)


11. GLOBAL MARKET PERSPECTIVE
Table 24: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Market by Test Type
Table 27: World Recent Past, Current & Future Analysis for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 30: World Recent Past, Current & Future Analysis for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31: World Historic Review for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for Apolipoprotein B Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 33: World Recent Past, Current & Future Analysis for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34: World Historic Review for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 35: World 14-Year Perspective for Other Cholesterol Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


III. MARKET


1. THE UNITED STATES
A.Market Analysis
Outlook
Surge in CVD Incidence - Major Growth Factor
Table 36: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)
Table 37: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)
Table 38: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)
Ageing Population - Vital Demography
Table 39: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
The Risk of CVD in Chronic Conditions to Drive Testing Market
Opportunity Indicators
Table 40: Obesity Prevalence in US Adults by Type of Obesity (2015) (includes corresponding Graph/Chart)
Table 41: Obesity Prevalence in the US by Age Group (2015) (includes corresponding Graph/Chart)
Table 42: Obesity Prevalence in the US by Percentage Annual Income Level of Adult Population (2015) (includes corresponding Graph/Chart)
Table 43: US Diabetics Population (2010-2030): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart)
Table 45: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Age Groups (includes corresponding Graph/Chart)
Table 46: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Ethnic Group (includes corresponding Graph/Chart)
Increasing Cardiovascular Ailments Drive Sales of Home Test Devices
Prospects and Challenges for Self-Testing Healthcare Devices Market
Regulatory Changes Support Self-Testing
Challenges
Cholesterol POCT Market: An Overview
Cholesterol Testing - NCEP Recommendations Spurs Potential
The Rx-to-OTC Switch Scenario
Electronic Health Records
Accountable Care Organizations
Managed Care Organizations
Changing Care Settings
Opportunities for Consumer Self Testing
Regulations in Self-Testing Market: Need for Change
Expanding Role of HCPs - A Step to Strengthen Self-Testing Market
Innovations Drive the Usage of Cardiovascular Monitoring Systems
Sterols and Stanols: Cholesterol-Lowering Products
Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 47: US Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 48: US Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 49: US 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2020 & 2022 (includes corresponding Graph/Chart)


2. CANADA
Market Analysis
Table 50: Canadian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 51: Canadian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 52: Canadian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


3. JAPAN
Market Analysis
Table 53: Japanese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2415 through 2422(includes corresponding Graph/Chart)
Table 54: Japanese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 55: Japanese 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2020 & 2022 (includes corresponding Graph/Chart)


4. EUROPE
A.Market Analysis
Current & Future Analysis
Innovative Healthcare Policies and Guidelines to Mitigate Cardio Vascular Diseases and High Cholesterol Patients
Europe's Cholesterol Problem Needs Serious Attention
EU's Reluctance to Act
Screening Children for Familial Hypercholesterolemia (FH)
EU-wide Campaigns
B.Market Analytics
Table 56: European Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 57: European Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 58: European 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 59: European Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 60: European Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 61: European 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE
Market Analysis
Table 62: French Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 63: French Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 64: French 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Outlook
Key Player
B.Market Analytics
Table 65: German Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 66: German Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 67: German 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4c. ITALY
Market Analysis
Table 68: Italian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 69: Italian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 70: Italian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
Market Analysis
Table 71: UK Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 72: UK Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 73: UK 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 74: Spanish Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 75: Spanish Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 76: Spanish 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4f. RUSSIA
Market Analysis
Table 77: Russian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 78: Russian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 79: Russian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
A.Market Analysis
Outlook
Product Launch
B.Market Analytics
Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 81: Rest of Europe Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 82: Rest of Europe 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


5. ASIA-PACIFIC
A.Market Analysis
The Largest Market Worldwide
B.Market Analytics
Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 84: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 85: Asia-Pacific 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for China, India, and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 87: Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 88: Asia-Pacific 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5a. CHINA
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 89: Chinese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 90: Chinese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 91: Chinese 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5b. INDIA
A.Market Analysis
Outlook
Corporate Development
B.Market Analytics
Table 92: Indian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 93: Indian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 94: Indian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC
A.Market Analysis
Outlook
B.Market Analytics
Table 95: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 96: Rest of Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 97: Rest of Asia-Pacific 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


6. LATIN AMERICA
Market Analysis
Table 98: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 99: Latin American Historic Review for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 100: Latin American 14-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for Brazil, and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
Table 101: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 102: Latin American Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 103: Latin American 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6a. BRAZIL
Market Analysis
Table 104: Brazilian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 105: Brazilian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 106: Brazilian 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA
Market Analysis
Table 107: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 108: Rest of Latin America Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 109: Rest of Latin America 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


7. REST OF WORLD
Market Analysis
Table 110: Rest of World Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 111: Rest of World Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 112: Rest of World 14-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)


IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 29 The United States (23) Canada (1) Japan (1) Europe (2) - Germany (1) - The United Kingdom (1) Asia-Pacific (Excluding Japan) (2)
Download the full report: https://www.reportbuyer.com/product/4484194/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-cholesterol-testing---clinical-diagnostics-300436339.html